Investment Trends

Hear Why J&J MedTech Is Ready to Move Forward with Ottava; A VC Discusses the Impact of GLP-1 drugs
November 10, 2023 • 0 Comment
GUEST: Rocco De Bernardis, Global President of OTTAVA. Johnson & Johnson Medtech GUEST CO-HOST: Karthik Bolisetty, Senior Associated at Gilde Healthcare SPONSOR: APTYX

In this week’s episode, we’ll speak with Rocco De Bernardis, Global President of OTTAVA, Johnson & Johnson MedTech. This week, J&J MedTech announced it was filing an IDE to begin clinical trials on its surgical robotics system, Ottava, in 2024. […]

Read More